$TLCC
Twinlab Consolidated Holdings Inc

2023 Q4 Form 10-Q Financial Statement

#000175392623001491 Filed on November 14, 2023

View on sec.gov

Income Statement

Concept 2023 Q4 2023 Q3
Revenue $3.144M $3.676M
YoY Change -66.33% -76.32%
Cost Of Revenue $2.130M $2.345M
YoY Change -67.08% -80.84%
Gross Profit $1.014M $1.331M
YoY Change -64.64% -59.47%
Gross Profit Margin 32.25% 36.21%
Selling, General & Admin $1.388M $1.533M
YoY Change -63.76% -63.02%
% of Gross Profit 136.88% 115.18%
Research & Development
YoY Change
% of Gross Profit
Depreciation & Amortization $2.000K $9.000K
YoY Change -95.35% -35.71%
% of Gross Profit 0.2% 0.68%
Operating Expenses $1.388M $1.533M
YoY Change -63.76% -63.02%
Operating Profit -$374.0K -$202.0K
YoY Change -61.12% -76.57%
Interest Expense -$1.842M $2.107M
YoY Change -9.08% 2.08%
% of Operating Profit
Other Income/Expense, Net $27.00K -$2.123M
YoY Change 2.86%
Pretax Income -$2.500M -$2.325M
YoY Change -24.88% -20.54%
Income Tax $11.00K $25.00K
% Of Pretax Income
Net Earnings -$1.548M -$5.364M
YoY Change -53.83% 83.32%
Net Earnings / Revenue -49.24% -145.92%
Basic Earnings Per Share -$0.02
Diluted Earnings Per Share -$0.01 -$0.02
COMMON SHARES
Basic Shares Outstanding 259.1M shares 259.1M shares
Diluted Shares Outstanding 259.1M shares

Balance Sheet

Concept 2023 Q4 2023 Q3
SHORT-TERM ASSETS
Cash & Short-Term Investments $19.00K $50.00K
YoY Change -97.81% -82.52%
Cash & Equivalents $19.00K $50.00K
Short-Term Investments
Other Short-Term Assets $194.0K $257.0K
YoY Change -74.41% -1.91%
Inventory $3.402M $4.400M
Prepaid Expenses
Receivables $2.072M $1.005M
Other Receivables $0.00 $0.00
Total Short-Term Assets $5.687M $5.712M
YoY Change -62.43% -69.17%
LONG-TERM ASSETS
Property, Plant & Equipment $9.000K $15.00K
YoY Change -95.21% -92.54%
Goodwill
YoY Change
Intangibles $120.0K $120.0K
YoY Change 0.0% -75.46%
Long-Term Investments
YoY Change
Other Assets $1.290M $1.274M
YoY Change -0.85% -2.08%
Total Long-Term Assets $3.308M $3.754M
YoY Change -42.71% -41.19%
TOTAL ASSETS
Total Short-Term Assets $5.687M $5.712M
Total Long-Term Assets $3.308M $3.754M
Total Assets $8.995M $9.466M
YoY Change -56.99% -62.0%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $6.803M $5.533M
YoY Change 2.75% 5.39%
Accrued Expenses $43.23M $41.16M
YoY Change 19.16% 10.52%
Deferred Revenue $2.149M $2.139M
YoY Change 13.05% 21.4%
Short-Term Debt $0.00 $0.00
YoY Change
Long-Term Debt Due $93.64M $95.35M
YoY Change -3.84% -4.69%
Total Short-Term Liabilities $145.8M $144.2M
YoY Change 2.56% 1.16%
LONG-TERM LIABILITIES
Long-Term Debt $0.00 $0.00
YoY Change
Other Long-Term Liabilities $2.197M $2.758M
YoY Change -45.59% -36.35%
Total Long-Term Liabilities $2.197M $2.758M
YoY Change -36.35%
TOTAL LIABILITIES
Total Short-Term Liabilities $145.8M $144.2M
Total Long-Term Liabilities $2.197M $2.758M
Total Liabilities $148.0M $146.9M
YoY Change 1.23% 0.05%
SHAREHOLDERS EQUITY
Retained Earnings -$370.1M -$368.6M
YoY Change 3.85% 4.4%
Common Stock $231.6M $231.6M
YoY Change 0.0% 0.0%
Preferred Stock
YoY Change
Treasury Stock (at cost) $500.0K $500.0K
YoY Change 0.0% 0.0%
Treasury Stock Shares
Shareholders Equity -$139.0M -$137.5M
YoY Change
Total Liabilities & Shareholders Equity $8.995M $9.466M
YoY Change -56.99% -62.0%

Cashflow Statement

Concept 2023 Q4 2023 Q3
OPERATING ACTIVITIES
Net Income -$1.548M -$5.364M
YoY Change -53.83% 83.32%
Depreciation, Depletion And Amortization $2.000K $9.000K
YoY Change -95.35% -35.71%
Cash From Operating Activities $1.680M $208.0K
YoY Change -48.12% -107.83%
INVESTING ACTIVITIES
Capital Expenditures $0.00 $0.00
YoY Change
Acquisitions
YoY Change
Other Investing Activities
YoY Change
Cash From Investing Activities $0.00 $0.00
YoY Change
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities -1.711M -298.0K
YoY Change -35.58% -110.64%
NET CHANGE
Cash From Operating Activities 1.680M 208.0K
Cash From Investing Activities 0.000 0.000
Cash From Financing Activities -1.711M -298.0K
Net Change In Cash -31.00K -90.00K
YoY Change -105.33% -162.5%
FREE CASH FLOW
Cash From Operating Activities $1.680M $208.0K
Capital Expenditures $0.00 $0.00
Free Cash Flow $1.680M $208.0K
YoY Change -48.12% -107.83%

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
CY2023Q3 us-gaap Intangible Assets Net Excluding Goodwill
IntangibleAssetsNetExcludingGoodwill
120000 usd
dei Document Fiscal Year Focus
DocumentFiscalYearFocus
2023
dei Document Fiscal Period Focus
DocumentFiscalPeriodFocus
Q3
dei Current Fiscal Year End Date
CurrentFiscalYearEndDate
--12-31
dei Amendment Flag
AmendmentFlag
false
dei Entity Central Index Key
EntityCentralIndexKey
0001590695
CY2023Q3 us-gaap Discontinued Operation Gain Loss On Disposal Statement Of Income Or Comprehensive Income Extensible Enumeration
DiscontinuedOperationGainLossOnDisposalStatementOfIncomeOrComprehensiveIncomeExtensibleEnumeration
http://fasb.org/us-gaap/2023#IncomeLossFromDiscontinuedOperationsNetOfTaxAttributableToReportingEntity
dei Document Type
DocumentType
10-Q
dei Document Quarterly Report
DocumentQuarterlyReport
true
dei Document Period End Date
DocumentPeriodEndDate
2023-09-30
dei Document Transition Report
DocumentTransitionReport
false
dei Entity File Number
EntityFileNumber
000-55181
dei Entity Registrant Name
EntityRegistrantName
Twinlab Consolidated Holdings, Inc.
dei Entity Incorporation State Country Code
EntityIncorporationStateCountryCode
NV
dei Entity Tax Identification Number
EntityTaxIdentificationNumber
46-3951742
dei Entity Address Address Line1
EntityAddressAddressLine1
4800 T-Rex Avenue, Suite 225
dei Entity Address City Or Town
EntityAddressCityOrTown
Boca Raton
dei Entity Address State Or Province
EntityAddressStateOrProvince
FL
dei Entity Address Postal Zip Code
EntityAddressPostalZipCode
33431
dei City Area Code
CityAreaCode
561
dei Local Phone Number
LocalPhoneNumber
443-4301
dei Entity Current Reporting Status
EntityCurrentReportingStatus
Yes
dei Entity Interactive Data Current
EntityInteractiveDataCurrent
Yes
dei Entity Filer Category
EntityFilerCategory
Non-accelerated Filer
dei Entity Small Business
EntitySmallBusiness
true
dei Entity Emerging Growth Company
EntityEmergingGrowthCompany
false
dei Entity Shell Company
EntityShellCompany
false
CY2023Q4 dei Entity Common Stock Shares Outstanding
EntityCommonStockSharesOutstanding
259092833 shares
CY2023Q3 us-gaap Cash
Cash
50000 usd
CY2022Q4 us-gaap Cash
Cash
866000 usd
CY2023Q3 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
1005000 usd
CY2022Q4 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
1217000 usd
CY2023Q3 us-gaap Inventory Net
InventoryNet
4400000 usd
CY2022Q4 us-gaap Inventory Net
InventoryNet
6864000 usd
CY2023Q3 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
257000 usd
CY2022Q4 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
319000 usd
CY2023Q3 us-gaap Assets Of Disposal Group Including Discontinued Operation Current
AssetsOfDisposalGroupIncludingDiscontinuedOperationCurrent
0 usd
CY2022Q4 us-gaap Assets Of Disposal Group Including Discontinued Operation Current
AssetsOfDisposalGroupIncludingDiscontinuedOperationCurrent
5872000 usd
CY2023Q3 us-gaap Assets Current
AssetsCurrent
5712000 usd
CY2022Q4 us-gaap Assets Current
AssetsCurrent
15138000 usd
CY2023Q3 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
15000 usd
CY2022Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
19000 usd
CY2023Q3 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
2345000 usd
CY2022Q4 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
2945000 usd
CY2022Q4 us-gaap Intangible Assets Net Excluding Goodwill
IntangibleAssetsNetExcludingGoodwill
120000 usd
CY2023Q3 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
1274000 usd
CY2022Q4 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
1255000 usd
CY2023Q3 us-gaap Disposal Group Including Discontinued Operation Assets Noncurrent
DisposalGroupIncludingDiscontinuedOperationAssetsNoncurrent
0 usd
CY2022Q4 us-gaap Disposal Group Including Discontinued Operation Assets Noncurrent
DisposalGroupIncludingDiscontinuedOperationAssetsNoncurrent
1435000 usd
CY2023Q3 us-gaap Assets
Assets
9466000 usd
CY2022Q4 us-gaap Assets
Assets
20912000 usd
CY2023Q3 us-gaap Accounts Payable Current
AccountsPayableCurrent
5533000 usd
CY2022Q4 us-gaap Accounts Payable Current
AccountsPayableCurrent
2487000 usd
CY2023Q3 us-gaap Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
1087000 usd
CY2022Q4 us-gaap Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
844000 usd
CY2023Q3 us-gaap Accounts Payable And Other Accrued Liabilities Current
AccountsPayableAndOtherAccruedLiabilitiesCurrent
3996000 usd
CY2022Q4 us-gaap Accounts Payable And Other Accrued Liabilities Current
AccountsPayableAndOtherAccruedLiabilitiesCurrent
1628000 usd
CY2023Q3 us-gaap Interest Payable Current
InterestPayableCurrent
38219000 usd
CY2022Q4 us-gaap Interest Payable Current
InterestPayableCurrent
33316000 usd
CY2023Q3 us-gaap Long Term Debt Current
LongTermDebtCurrent
95349000 usd
CY2022Q4 us-gaap Long Term Debt Current
LongTermDebtCurrent
97381000 usd
CY2023Q3 us-gaap Liabilities Of Disposal Group Including Discontinued Operation Current
LiabilitiesOfDisposalGroupIncludingDiscontinuedOperationCurrent
0 usd
CY2022Q4 us-gaap Liabilities Of Disposal Group Including Discontinued Operation Current
LiabilitiesOfDisposalGroupIncludingDiscontinuedOperationCurrent
6530000 usd
CY2023Q3 us-gaap Liabilities Current
LiabilitiesCurrent
144184000 usd
CY2022Q4 us-gaap Liabilities Current
LiabilitiesCurrent
142186000 usd
CY2023Q3 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
2758000 usd
CY2022Q4 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
3090000 usd
CY2023Q3 us-gaap Liabilities Of Disposal Group Including Discontinued Operation Noncurrent
LiabilitiesOfDisposalGroupIncludingDiscontinuedOperationNoncurrent
0 usd
CY2022Q4 us-gaap Liabilities Of Disposal Group Including Discontinued Operation Noncurrent
LiabilitiesOfDisposalGroupIncludingDiscontinuedOperationNoncurrent
947000 usd
CY2023Q3 us-gaap Liabilities Noncurrent
LiabilitiesNoncurrent
2758000 usd
CY2022Q4 us-gaap Liabilities Noncurrent
LiabilitiesNoncurrent
4037000 usd
CY2023Q3 us-gaap Liabilities
Liabilities
146942000 usd
CY2022Q4 us-gaap Liabilities
Liabilities
146223000 usd
CY2022Q4 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.001
CY2023Q3 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.001
CY2022Q4 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
500000000 shares
CY2023Q3 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
500000000 shares
CY2023Q3 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
0 shares
CY2022Q4 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
0 shares
CY2022Q4 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
0 shares
CY2023Q3 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
0 shares
CY2023Q3 us-gaap Preferred Stock Value
PreferredStockValue
0 usd
CY2022Q4 us-gaap Preferred Stock Value
PreferredStockValue
0 usd
CY2022Q4 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.001
CY2023Q3 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.001
CY2022Q4 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
5000000000 shares
CY2023Q3 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
5000000000 shares
CY2023Q3 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
393898884 shares
CY2022Q4 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
393898884 shares
CY2023Q3 us-gaap Common Stock Value
CommonStockValue
394000 usd
CY2022Q4 us-gaap Common Stock Value
CommonStockValue
394000 usd
CY2023Q3 us-gaap Additional Paid In Capital Common Stock
AdditionalPaidInCapitalCommonStock
231249000 usd
CY2022Q4 us-gaap Additional Paid In Capital Common Stock
AdditionalPaidInCapitalCommonStock
231249000 usd
CY2023Q3 us-gaap Common Stock Share Subscribed But Unissued Subscriptions Receivable
CommonStockShareSubscribedButUnissuedSubscriptionsReceivable
30000 usd
CY2022Q4 us-gaap Common Stock Share Subscribed But Unissued Subscriptions Receivable
CommonStockShareSubscribedButUnissuedSubscriptionsReceivable
30000 usd
CY2022Q4 us-gaap Treasury Stock Common Shares
TreasuryStockCommonShares
134806051 shares
CY2023Q3 us-gaap Treasury Stock Common Shares
TreasuryStockCommonShares
134806051 shares
CY2023Q3 us-gaap Treasury Stock Value
TreasuryStockValue
500000 usd
CY2022Q4 us-gaap Treasury Stock Value
TreasuryStockValue
500000 usd
CY2023Q3 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-368589000 usd
CY2022Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-356424000 usd
CY2023Q3 us-gaap Stockholders Equity
StockholdersEquity
-137476000 usd
CY2022Q4 us-gaap Stockholders Equity
StockholdersEquity
-125311000 usd
CY2023Q3 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
9466000 usd
CY2022Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
20912000 usd
CY2023Q3 us-gaap Revenue From Contract With Customer Including Assessed Tax
RevenueFromContractWithCustomerIncludingAssessedTax
3676000 usd
CY2022Q3 us-gaap Revenue From Contract With Customer Including Assessed Tax
RevenueFromContractWithCustomerIncludingAssessedTax
4597000 usd
us-gaap Revenue From Contract With Customer Including Assessed Tax
RevenueFromContractWithCustomerIncludingAssessedTax
10473000 usd
us-gaap Revenue From Contract With Customer Including Assessed Tax
RevenueFromContractWithCustomerIncludingAssessedTax
14271000 usd
CY2023Q3 us-gaap Cost Of Goods And Services Sold
CostOfGoodsAndServicesSold
2345000 usd
CY2022Q3 us-gaap Cost Of Goods And Services Sold
CostOfGoodsAndServicesSold
2711000 usd
us-gaap Cost Of Goods And Services Sold
CostOfGoodsAndServicesSold
6475000 usd
us-gaap Cost Of Goods And Services Sold
CostOfGoodsAndServicesSold
7868000 usd
CY2023Q3 us-gaap Gross Profit
GrossProfit
1331000 usd
CY2022Q3 us-gaap Gross Profit
GrossProfit
1886000 usd
us-gaap Gross Profit
GrossProfit
3998000 usd
us-gaap Gross Profit
GrossProfit
6403000 usd
CY2023Q3 us-gaap Selling Expense
SellingExpense
342000 usd
CY2022Q3 us-gaap Selling Expense
SellingExpense
784000 usd
us-gaap Selling Expense
SellingExpense
933000 usd
us-gaap Selling Expense
SellingExpense
2262000 usd
CY2023Q3 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
1191000 usd
CY2022Q3 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
2019000 usd
us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
3769000 usd
us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
4889000 usd
CY2023Q3 us-gaap Operating Income Loss
OperatingIncomeLoss
-202000 usd
CY2022Q3 us-gaap Operating Income Loss
OperatingIncomeLoss
-917000 usd
us-gaap Operating Income Loss
OperatingIncomeLoss
-704000 usd
us-gaap Operating Income Loss
OperatingIncomeLoss
-748000 usd
CY2023Q3 us-gaap Interest Expense
InterestExpense
2107000 usd
CY2022Q3 us-gaap Interest Expense
InterestExpense
2064000 usd
us-gaap Interest Expense
InterestExpense
6429000 usd
us-gaap Interest Expense
InterestExpense
5876000 usd
CY2023Q3 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
-16000 usd
CY2022Q3 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
0 usd
us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
14000 usd
us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
1676000 usd
CY2023Q3 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
-2123000 usd
CY2022Q3 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
-2064000 usd
us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
-6415000 usd
us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
-4200000 usd
CY2023Q3 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-2325000 usd
CY2022Q3 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-2981000 usd
us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-7119000 usd
us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-4948000 usd
CY2023Q3 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
25000 usd
CY2022Q3 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
0 usd
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
32000 usd
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
0 usd
CY2023Q3 us-gaap Income Loss From Continuing Operations
IncomeLossFromContinuingOperations
-2350000 usd
CY2022Q3 us-gaap Income Loss From Continuing Operations
IncomeLossFromContinuingOperations
-2981000 usd
us-gaap Income Loss From Continuing Operations
IncomeLossFromContinuingOperations
-7151000 usd
us-gaap Income Loss From Continuing Operations
IncomeLossFromContinuingOperations
-4948000 usd
CY2022Q3 us-gaap Income Loss From Discontinued Operations Net Of Tax Attributable To Reporting Entity
IncomeLossFromDiscontinuedOperationsNetOfTaxAttributableToReportingEntity
55000 usd
us-gaap Income Loss From Discontinued Operations Net Of Tax Attributable To Reporting Entity
IncomeLossFromDiscontinuedOperationsNetOfTaxAttributableToReportingEntity
-5015000 usd
us-gaap Income Loss From Discontinued Operations Net Of Tax Attributable To Reporting Entity
IncomeLossFromDiscontinuedOperationsNetOfTaxAttributableToReportingEntity
79000 usd
CY2023Q3 us-gaap Net Income Loss
NetIncomeLoss
-5364000 usd
CY2022Q3 us-gaap Net Income Loss
NetIncomeLoss
-2926000 usd
us-gaap Net Income Loss
NetIncomeLoss
-12166000 usd
us-gaap Net Income Loss
NetIncomeLoss
-4869000 usd
CY2023Q3 us-gaap Income Loss From Continuing Operations Per Basic Share
IncomeLossFromContinuingOperationsPerBasicShare
-0.01
CY2022Q3 us-gaap Income Loss From Continuing Operations Per Basic Share
IncomeLossFromContinuingOperationsPerBasicShare
-0.01
us-gaap Income Loss From Continuing Operations Per Basic Share
IncomeLossFromContinuingOperationsPerBasicShare
-0.03
us-gaap Income Loss From Continuing Operations Per Basic Share
IncomeLossFromContinuingOperationsPerBasicShare
-0.02
CY2023Q3 us-gaap Income Loss From Continuing Operations Per Diluted Share
IncomeLossFromContinuingOperationsPerDilutedShare
-0.01
CY2022Q3 us-gaap Income Loss From Continuing Operations Per Diluted Share
IncomeLossFromContinuingOperationsPerDilutedShare
-0.01
us-gaap Income Loss From Continuing Operations Per Diluted Share
IncomeLossFromContinuingOperationsPerDilutedShare
-0.03
us-gaap Income Loss From Continuing Operations Per Diluted Share
IncomeLossFromContinuingOperationsPerDilutedShare
-0.02
CY2023Q3 us-gaap Income Loss From Discontinued Operations Net Of Tax Per Basic Share
IncomeLossFromDiscontinuedOperationsNetOfTaxPerBasicShare
-0.01
CY2022Q3 us-gaap Income Loss From Discontinued Operations Net Of Tax Per Basic Share
IncomeLossFromDiscontinuedOperationsNetOfTaxPerBasicShare
0
us-gaap Income Loss From Discontinued Operations Net Of Tax Per Basic Share
IncomeLossFromDiscontinuedOperationsNetOfTaxPerBasicShare
-0.01
us-gaap Income Loss From Discontinued Operations Net Of Tax Per Basic Share
IncomeLossFromDiscontinuedOperationsNetOfTaxPerBasicShare
0
CY2023Q3 us-gaap Income Loss From Discontinued Operations Net Of Tax Per Diluted Share
IncomeLossFromDiscontinuedOperationsNetOfTaxPerDilutedShare
-0.01
CY2022Q3 us-gaap Income Loss From Discontinued Operations Net Of Tax Per Diluted Share
IncomeLossFromDiscontinuedOperationsNetOfTaxPerDilutedShare
0
us-gaap Income Loss From Discontinued Operations Net Of Tax Per Diluted Share
IncomeLossFromDiscontinuedOperationsNetOfTaxPerDilutedShare
-0.01
us-gaap Income Loss From Discontinued Operations Net Of Tax Per Diluted Share
IncomeLossFromDiscontinuedOperationsNetOfTaxPerDilutedShare
0
CY2023Q3 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
259092833 shares
CY2022Q3 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
259092833 shares
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
259092833 shares
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
259092833 shares
CY2023Q3 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.02
CY2022Q3 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.01
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.02
CY2023Q3 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
259092833 shares
CY2022Q3 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
259092833 shares
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
259092833 shares
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
259092833 shares
CY2023Q3 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.02
CY2022Q3 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.01
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.05
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.02
CY2021Q4 us-gaap Stockholders Equity
StockholdersEquity
-117089000 usd
CY2022Q1 us-gaap Net Income Loss
NetIncomeLoss
276000 usd
CY2022Q1 us-gaap Stockholders Equity
StockholdersEquity
-116813000 usd
CY2022Q2 us-gaap Net Income Loss
NetIncomeLoss
-2219000 usd
CY2022Q2 us-gaap Stockholders Equity
StockholdersEquity
-119032000 usd
CY2022Q3 us-gaap Net Income Loss
NetIncomeLoss
-2926000 usd
CY2022Q3 us-gaap Stockholders Equity
StockholdersEquity
-121958000 usd
CY2022Q4 us-gaap Stockholders Equity
StockholdersEquity
-125311000 usd
CY2023Q1 us-gaap Net Income Loss
NetIncomeLoss
-2810000 usd
CY2023Q1 us-gaap Stockholders Equity
StockholdersEquity
-128121000 usd
CY2023Q2 us-gaap Net Income Loss
NetIncomeLoss
-3991000 usd
CY2023Q2 us-gaap Stockholders Equity
StockholdersEquity
-132112000 usd
CY2023Q3 us-gaap Net Income Loss
NetIncomeLoss
-5364000 usd
CY2023Q3 us-gaap Stockholders Equity
StockholdersEquity
-137476000 usd
us-gaap Net Income Loss
NetIncomeLoss
-12166000 usd
us-gaap Net Income Loss
NetIncomeLoss
-4869000 usd
us-gaap Income Loss From Discontinued Operations Net Of Tax Attributable To Reporting Entity
IncomeLossFromDiscontinuedOperationsNetOfTaxAttributableToReportingEntity
-5015000 usd
us-gaap Income Loss From Discontinued Operations Net Of Tax Attributable To Reporting Entity
IncomeLossFromDiscontinuedOperationsNetOfTaxAttributableToReportingEntity
79000 usd
us-gaap Income Loss From Continuing Operations
IncomeLossFromContinuingOperations
-7151000 usd
us-gaap Income Loss From Continuing Operations
IncomeLossFromContinuingOperations
-4948000 usd
us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
33000 usd
us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
125000 usd
us-gaap Operating Lease Right Of Use Asset Amortization Expense
OperatingLeaseRightOfUseAssetAmortizationExpense
1820000 usd
us-gaap Operating Lease Right Of Use Asset Amortization Expense
OperatingLeaseRightOfUseAssetAmortizationExpense
715000 usd
us-gaap Inventory Write Down
InventoryWriteDown
485000 usd
us-gaap Inventory Write Down
InventoryWriteDown
-547000 usd
us-gaap Provision For Doubtful Accounts
ProvisionForDoubtfulAccounts
1499000 usd
us-gaap Provision For Doubtful Accounts
ProvisionForDoubtfulAccounts
-391000 usd
us-gaap Gains Losses On Extinguishment Of Debt
GainsLossesOnExtinguishmentOfDebt
0 usd
us-gaap Gains Losses On Extinguishment Of Debt
GainsLossesOnExtinguishmentOfDebt
1674000 usd
us-gaap Other Noncash Income Expense
OtherNoncashIncomeExpense
-140000 usd
us-gaap Other Noncash Income Expense
OtherNoncashIncomeExpense
-373000 usd
us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
-1601000 usd
us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
152000 usd
us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
-4523000 usd
us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
4192000 usd
us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
-502000 usd
us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
-783000 usd
us-gaap Increase Decrease In Other Operating Assets
IncreaseDecreaseInOtherOperatingAssets
-28000 usd
us-gaap Increase Decrease In Other Operating Assets
IncreaseDecreaseInOtherOperatingAssets
0 usd
us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
-1088000 usd
us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
-797000 usd
us-gaap Increase Decrease In Operating Lease Liability
IncreaseDecreaseInOperatingLeaseLiability
-1352000 usd
us-gaap Increase Decrease In Operating Lease Liability
IncreaseDecreaseInOperatingLeaseLiability
-767000 usd
us-gaap Increase Decrease In Accrued Liabilities And Other Operating Liabilities
IncreaseDecreaseInAccruedLiabilitiesAndOtherOperatingLiabilities
5191000 usd
us-gaap Increase Decrease In Accrued Liabilities And Other Operating Liabilities
IncreaseDecreaseInAccruedLiabilitiesAndOtherOperatingLiabilities
3844000 usd
us-gaap Net Cash Provided By Used In Operating Activities Continuing Operations
NetCashProvidedByUsedInOperatingActivitiesContinuingOperations
1216000 usd
us-gaap Net Cash Provided By Used In Operating Activities Continuing Operations
NetCashProvidedByUsedInOperatingActivitiesContinuingOperations
-7549000 usd
us-gaap Cash Provided By Used In Operating Activities Discontinued Operations
CashProvidedByUsedInOperatingActivitiesDiscontinuedOperations
1000 usd
us-gaap Cash Provided By Used In Operating Activities Discontinued Operations
CashProvidedByUsedInOperatingActivitiesDiscontinuedOperations
0 usd
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
1217000 usd
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-7549000 usd
us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
0 usd
us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
99000 usd
us-gaap Net Cash Provided By Used In Investing Activities Continuing Operations
NetCashProvidedByUsedInInvestingActivitiesContinuingOperations
0 usd
us-gaap Net Cash Provided By Used In Investing Activities Continuing Operations
NetCashProvidedByUsedInInvestingActivitiesContinuingOperations
-99000 usd
us-gaap Cash Provided By Used In Investing Activities Discontinued Operations
CashProvidedByUsedInInvestingActivitiesDiscontinuedOperations
0 usd
us-gaap Cash Provided By Used In Investing Activities Discontinued Operations
CashProvidedByUsedInInvestingActivitiesDiscontinuedOperations
0 usd
us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
0 usd
us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-99000 usd
us-gaap Proceeds From Repayments Of Lines Of Credit
ProceedsFromRepaymentsOfLinesOfCredit
-2033000 usd
us-gaap Proceeds From Repayments Of Lines Of Credit
ProceedsFromRepaymentsOfLinesOfCredit
4303000 usd
us-gaap Net Cash Provided By Used In Financing Activities Continuing Operations
NetCashProvidedByUsedInFinancingActivitiesContinuingOperations
-2033000 usd
us-gaap Net Cash Provided By Used In Financing Activities Continuing Operations
NetCashProvidedByUsedInFinancingActivitiesContinuingOperations
4303000 usd
us-gaap Cash Provided By Used In Financing Activities Discontinued Operations
CashProvidedByUsedInFinancingActivitiesDiscontinuedOperations
0 usd
us-gaap Cash Provided By Used In Financing Activities Discontinued Operations
CashProvidedByUsedInFinancingActivitiesDiscontinuedOperations
0 usd
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
-2033000 usd
us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
-816000 usd
us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
-3345000 usd
CY2022Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
866000 usd
CY2021Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
3631000 usd
CY2023Q3 us-gaap Contract With Customer Liability Current
ContractWithCustomerLiabilityCurrent
2139000 usd
CY2022Q4 us-gaap Contract With Customer Liability Current
ContractWithCustomerLiabilityCurrent
1901000 usd
CY2022Q4 us-gaap Contract With Customer Refund Liability Current
ContractWithCustomerRefundLiabilityCurrent
45000 usd
CY2023Q3 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
50000 usd
CY2022Q3 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
286000 usd
us-gaap Interest Paid Net
InterestPaidNet
1068000 usd
us-gaap Interest Paid Net
InterestPaidNet
1033000 usd
us-gaap Nature Of Operations
NatureOfOperations
<p style="margin-top: 0pt; margin-bottom: 0pt; font-size: 10pt; line-height: 1.2;"><span style="font-family: 'Times New Roman'; font-weight: bold; line-height: inherit;">Note </span><span style="font-family: 'Times New Roman'; font-weight: bold; line-height: inherit;"><span style="border-left: none; border-right: none; line-height: inherit;"><span>1</span></span></span> <span style="font-family: 'Times New Roman'; line-height: inherit;">–</span><span style="font-family: 'Times New Roman'; font-weight: bold; line-height: inherit;"> Nature of Business </span></p> <p style="margin-top: 0pt; margin-bottom: 0pt; font-size: 10pt; line-height: 1.2;"><span style="font-family: 'Times New Roman'; line-height: inherit;"> </span></p> <p style="margin-top: 0pt; margin-bottom: 0pt; font-size: 10pt; line-height: 1.2;"><span style="font-family: 'Times New Roman'; font-style: italic; line-height: inherit;">Nature of Business</span></p> <p style="margin-top: 0pt; margin-bottom: 0pt; font-size: 10pt; line-height: 1.2;"><span style="font-family: 'Times New Roman'; line-height: inherit;"> </span></p> <p style="margin-top: 0pt; margin-bottom: 0pt; text-indent: 27pt; text-align: justify; font-size: 10pt; line-height: 1.2;"><span style="font-family: 'Times New Roman'; line-height: inherit;">Twinlab Consolidated Holdings, Inc. (the “Company”, “Twinlab,” “we,” “our” and “us”) was incorporated on </span><span style="font-family: 'Times New Roman'; line-height: inherit;">October 24, 2013 </span><span style="font-family: 'Times New Roman'; line-height: inherit;">under the laws of the State of Nevada as Mirror Me, Inc. On </span><span style="font-family: 'Times New Roman'; line-height: inherit;">August 7, 2014, </span><span style="font-family: 'Times New Roman'; line-height: inherit;">we amended our articles of incorporation and changed our name to Twinlab Consolidated Holdings, Inc.</span></p> <p style="margin-top: 0pt; margin-bottom: 0pt; font-size: 10pt; line-height: 1.2;"><span style="font-family: 'Times New Roman'; line-height: inherit;"> </span></p> <p style="margin-top: 0pt; margin-bottom: 0pt; text-indent: 27pt; text-align: justify; font-size: 10pt; line-height: 1.2;"><span style="font-family: 'Times New Roman'; line-height: inherit;">We are an integrated marketer, distributor, and retailer of branded nutritional supplements and other natural products sold to and through domestic health and natural food stores, mass market retailers, specialty store retailers, on-line retailers, and websites. Internationally, we market and distribute branded nutritional supplements and other natural products to and through health and natural product distributors and retailers.</span></p> <p style="margin-top: 0pt; margin-bottom: 0pt; font-size: 10pt; line-height: 1.2;"><span style="font-family: 'Times New Roman'; line-height: inherit;"> </span></p> <p style="margin-top: 0pt; margin-bottom: 0pt; text-indent: 27pt; text-align: justify; font-size: 10pt; line-height: 1.2;"><span style="font-family: 'Times New Roman'; line-height: inherit;">Our products include vitamins, minerals, specialty supplements and sports nutrition products sold under the Twinlab<span style="color: #000000; font-family: 'Times New Roman'; font-size: 13.3333px; font-style: normal; font-variant-ligatures: normal; font-variant-caps: normal; font-weight: 400; letter-spacing: normal; orphans: 2; text-align: justify; text-indent: 36px; text-transform: none; white-space: normal; widows: 2; word-spacing: 0px; -webkit-text-stroke-width: 0px; text-decoration-thickness: initial; text-decoration-style: initial; text-decoration-color: initial; float: none; display: inline !important; line-height: inherit;">®</span> brand name, a market leader in the healthy aging and beauty from within categories sold under the Reserveage Nutrition and ResVitale® brand names; diet and energy products sold under the Metabolife<span style="color: #000000; font-family: 'Times New Roman'; font-size: 13.3333px; font-style: normal; font-variant-ligatures: normal; font-variant-caps: normal; font-weight: 400; letter-spacing: normal; orphans: 2; text-align: justify; text-indent: 36px; text-transform: none; white-space: normal; widows: 2; word-spacing: 0px; -webkit-text-stroke-width: 0px; text-decoration-thickness: initial; text-decoration-style: initial; text-decoration-color: initial; float: none; display: inline !important; line-height: inherit;">®</span> brand name; and a full line of herbal teas sold under the Alvita<span style="color: #000000; font-family: 'Times New Roman'; font-size: 13.3333px; font-style: normal; font-variant-ligatures: normal; font-variant-caps: normal; font-weight: 400; letter-spacing: normal; orphans: 2; text-align: justify; text-indent: 36px; text-transform: none; white-space: normal; widows: 2; word-spacing: 0px; -webkit-text-stroke-width: 0px; text-decoration-thickness: initial; text-decoration-style: initial; text-decoration-color: initial; float: none; display: inline !important; line-height: inherit;">®</span> brand name. To accommodate consumer preferences, our products come in various formulations and delivery forms, including capsules, tablets, softgels, chewables, liquids, sprays and powders. These products are sold primarily through health and natural food stores and on-line retailers, supermarkets, and mass-market retailers.</span><span style="font-family: 'Times New Roman'; line-height: inherit;"> </span></p> <p style="margin-top: 0pt; margin-bottom: 0pt; font-size: 10pt; line-height: 1.2;"><span style="font-family: 'Times New Roman'; line-height: inherit;"> </span></p> <p style="margin-top: 0pt; margin-bottom: 0pt; text-indent: 27pt; text-align: justify; font-size: 10pt; line-height: 1.2;"><span style="font-family: 'Times New Roman'; line-height: inherit;">We also performed services between private label distributors and contract manufacturers under the NutraScience Labs (“NSL”) brand name. NSL facilitated the production of new supplements to market and reformulated existing products to include scientifically-backed ingredients. We provided our customers with numerous production services, including manufacturing, testing, label and packaging design, order fulfillment, and regulatory compliance.</span></p> <p style="margin-top: 0pt; margin-bottom: 0pt; font-size: 10pt; line-height: 1.2;"><span style="font-family: 'Times New Roman'; line-height: inherit;"> </span></p> <p style="margin-top: 0pt; margin-bottom: 0pt; text-indent: 27pt; text-align: justify; font-size: 10pt; line-height: 1.2;"><span style="font-family: 'Times New Roman'; line-height: inherit;">NSL facilitated the contract manufacture of a variety of high-quality vitamin and supplement products, including but </span><span style="font-family: 'Times New Roman'; line-height: inherit;">not</span><span style="font-family: 'Times New Roman'; line-height: inherit;"> limited to, immune support supplements, cognitive support products, prebiotics and probiotics, supplements for weight management, and sports nutrition supplements. Our role in the production of these products was to help our customers manufacture or reformulate dietary supplements for sale and distribution. We did this by working with contract manufacturers to build scientifically backed formulas for resale to our end customers. We also simplified the production process by providing quality control checks, storing inventory on site, labeling and designing finished products, and drop shipping finished products ready for sale to our end customers. We did </span><span style="font-family: 'Times New Roman'; line-height: inherit;">not</span><span style="font-family: 'Times New Roman'; line-height: inherit;"> market these private label products, but rather sold the products to the customer, who was then responsible for the marketing, distribution, and sale to retailers or to their end customers. <span style="color: #000000; font-family: 'Times New Roman'; font-size: 13.3333px; font-style: normal; font-variant-ligatures: normal; font-variant-caps: normal; font-weight: 400; letter-spacing: normal; orphans: 2; text-align: justify; text-indent: 36px; text-transform: none; widows: 2; word-spacing: 0px; -webkit-text-stroke-width: 0px; white-space: normal; text-decoration-thickness: initial; text-decoration-style: initial; text-decoration-color: initial; float: none; display: inline !important;">The services performed under NSL ceased with the abandonment of operations that began in July 2023.</span></span></p> <p style="margin-top: 0pt; margin-bottom: 0pt; font-size: 10pt; line-height: 1.2;"><span style="font-family: 'Times New Roman'; line-height: inherit;"> </span></p> <p style="margin-top: 0pt; margin-bottom: 0pt; font-size: 10pt; line-height: 1.2;"><span style="font-family: 'Times New Roman'; font-style: italic; line-height: inherit;">Going Concern</span></p> <p style="margin-top: 0pt; margin-bottom: 0pt; font-size: 10pt; line-height: 1.2;"><span style="font-family: 'Times New Roman'; line-height: inherit;"> </span></p> <p style="margin-top: 0pt; margin-bottom: 0pt; text-indent: 27pt; text-align: justify; font-size: 10pt; line-height: 1.2;"><span style="font-family: 'Times New Roman'; line-height: inherit;">The accompanying condensed consolidated financial statements have been prepared on a going concern basis, which assumes continuity of operations and realization of assets and liabilities in the ordinary course of business. As of </span><span style="font-family: 'Times New Roman'; line-height: inherit;"><span>September 30, 2023</span>, </span><span style="font-family: 'Times New Roman'; line-height: inherit;">we had an accumulated def<span style="line-height: inherit;">icit of $</span></span><span style="line-height: inherit;"><span style="font-family: 'Times New Roman'; line-height: inherit;">368,589</span></span><span style="font-family: 'Times New Roman'; line-height: inherit;">. <span style="line-height: inherit;">Historical losses are primarily attributable to lower than planned sales resulting from low fill rates on demand due to limitations of our working capital, delayed product introductions and postponed marketing activities, merger-related and other restructuring costs as well as the abandonment of operations of NSL, and interest and refinancing charges associated with our debt refinancing.</span> Losses have been funded primarily through debt.</span></p> <p style="margin-top: 0pt; margin-bottom: 0pt; font-size: 10pt; line-height: 1.2;"><span style="font-family: 'Times New Roman'; line-height: inherit;"> </span></p> <p style="margin-top: 0pt; margin-bottom: 0pt; text-indent: 27pt; text-align: justify; font-size: 10pt; line-height: 1.2;"><span style="font-family: 'Times New Roman'; line-height: inherit;">Because of our history of operating losses and significant interest expense on our debt, we have a working capital deficiency of $</span><span style="font-family: 'Times New Roman'; line-height: inherit;"><span style="border-left: none; border-right: none; line-height: inherit;">138,472</span></span><span style="font-family: 'Times New Roman'; line-height: inherit;"> as of <span style="color: #000000; font-family: 'Times New Roman'; font-size: 13.3333px; font-style: normal; font-variant-ligatures: normal; font-variant-caps: normal; font-weight: 400; letter-spacing: normal; orphans: 2; text-align: justify; text-indent: 36px; text-transform: none; white-space: normal; widows: 2; word-spacing: 0px; -webkit-text-stroke-width: 0px; text-decoration-thickness: initial; text-decoration-style: initial; text-decoration-color: initial; float: none; display: inline !important; line-height: inherit;"><span>September 30, 2023</span></span></span><span style="font-family: 'Times New Roman'; line-height: inherit;">. </span><span style="font-family: 'Times New Roman'; line-height: inherit;">We also have $</span><span style="font-family: 'Times New Roman'; line-height: inherit;">95,349</span><span style="font-family: 'Times New Roman'; line-height: inherit;"> of debt, presented in current liabilities. These continuing conditions, among others, raise substantial doubt about our ability to continue as a going concern.</span></p> <p style="margin-top: 0pt; margin-bottom: 0pt; font-size: 10pt; line-height: 1.2;"><span style="font-family: 'Times New Roman'; line-height: inherit;"> </span></p> <p style="margin-top: 0pt; margin-bottom: 0pt; text-indent: 27pt; text-align: justify; font-size: 10pt; line-height: 1.2;"><span style="font-family: 'Times New Roman'; line-height: inherit;">Management is addressing operating issues through the following actions: <span style="line-height: inherit;">focusing on growing the core business and brands; continuing emphasis on major customers and key products; and continuing to negotiate lower prices from major suppliers</span>. </span><span style="font-family: 'Times New Roman'; line-height: inherit;">We will need to raise additional capital through debt, equity or the sale of assets during the current year</span><span style="font-family: 'Times New Roman'; line-height: inherit;">. There can be </span><span style="font-family: 'Times New Roman'; line-height: inherit;">no</span><span style="font-family: 'Times New Roman'; line-height: inherit;"> assurance that sources of funding will be available when needed on acceptable terms or at all. If we cannot obtain additional funding when required, the Company may sell certain assets, enter into collaborations, strategic alliances, merger and acquisition activities, and licensing agreements, negotiate with its principal lenders, wind-up operations of other subsidiaries, or file for bankruptcy protection.</span></p>
CY2023Q3 tlcc Working Capital Deficiency
WorkingCapitalDeficiency
138472000 usd
CY2023Q3 us-gaap Long Term Debt Current
LongTermDebtCurrent
95349000 usd
us-gaap Use Of Estimates
UseOfEstimates
<p style="margin-top: 0pt; margin-bottom: 0pt; font-size: 10pt;"><span style="font-family: 'times new roman', times; font-style: italic; font-size: 10pt; line-height: inherit;">Use of Estimates</span></p> <p style="margin-top: 0pt; margin-bottom: 0pt; font-size: 10pt;"><span style="font-family: 'times new roman', times; font-size: 10pt; line-height: inherit;"> </span></p> <p style="margin-top: 0pt; margin-bottom: 0pt; text-indent: 27pt; text-align: justify; font-size: 10pt; line-height: 1.2;"><span style="font-family: 'times new roman', times; font-size: 10pt; line-height: inherit;">The preparation of financial statements in conformity with GAAP requires management to make estimates and assumptions that affect certain reported amounts and disclosures. Actual results could differ from those estimates. Significant management estimates include those with respect to returns and allowances, allowance for doubtful accounts receivable, allowance for credit losses, reserves for inventory obsolescence, the recoverability of long-lived assets, intangibles and goodwill.</span></p>
CY2023Q3 tlcc Contract With Customer Liability Customer Deposits Current
ContractWithCustomerLiabilityCustomerDepositsCurrent
2098000 usd
CY2022Q4 tlcc Contract With Customer Liability Customer Deposits Current
ContractWithCustomerLiabilityCustomerDepositsCurrent
1856000 usd
CY2023Q3 us-gaap Contract With Customer Refund Liability Current
ContractWithCustomerRefundLiabilityCurrent
41000 usd
CY2023Q3 us-gaap Revenue From Contract With Customer Including Assessed Tax
RevenueFromContractWithCustomerIncludingAssessedTax
3676000 usd
CY2022Q3 us-gaap Revenue From Contract With Customer Including Assessed Tax
RevenueFromContractWithCustomerIncludingAssessedTax
4597000 usd
us-gaap Revenue From Contract With Customer Including Assessed Tax
RevenueFromContractWithCustomerIncludingAssessedTax
10473000 usd
us-gaap Revenue From Contract With Customer Including Assessed Tax
RevenueFromContractWithCustomerIncludingAssessedTax
14271000 usd
CY2023Q3 us-gaap Contract With Customer Asset Accumulated Allowance For Credit Loss
ContractWithCustomerAssetAccumulatedAllowanceForCreditLoss
3045000 usd
CY2023Q3 us-gaap Allowance For Doubtful Accounts Receivable Current
AllowanceForDoubtfulAccountsReceivableCurrent
2294000 usd
CY2023Q3 tlcc Accounts Receivable Allowance For Expected Credit Loss Current
AccountsReceivableAllowanceForExpectedCreditLossCurrent
32000 usd
CY2022Q4 us-gaap Contract With Customer Asset Accumulated Allowance For Credit Loss
ContractWithCustomerAssetAccumulatedAllowanceForCreditLoss
1546000 usd
CY2022Q4 us-gaap Allowance For Doubtful Accounts Receivable Current
AllowanceForDoubtfulAccountsReceivableCurrent
534000 usd
CY2023Q3 us-gaap Income Loss From Continuing Operations
IncomeLossFromContinuingOperations
-2350000 usd
CY2022Q3 us-gaap Income Loss From Continuing Operations
IncomeLossFromContinuingOperations
-2981000 usd
us-gaap Income Loss From Continuing Operations
IncomeLossFromContinuingOperations
-7151000 usd
CY2023Q3 us-gaap Income Loss From Discontinued Operations Net Of Tax Attributable To Reporting Entity
IncomeLossFromDiscontinuedOperationsNetOfTaxAttributableToReportingEntity
-3014000 usd
CY2022Q3 us-gaap Income Loss From Discontinued Operations Net Of Tax Attributable To Reporting Entity
IncomeLossFromDiscontinuedOperationsNetOfTaxAttributableToReportingEntity
55000 usd
us-gaap Income Loss From Discontinued Operations Net Of Tax Attributable To Reporting Entity
IncomeLossFromDiscontinuedOperationsNetOfTaxAttributableToReportingEntity
-5015000 usd
us-gaap Income Loss From Discontinued Operations Net Of Tax Attributable To Reporting Entity
IncomeLossFromDiscontinuedOperationsNetOfTaxAttributableToReportingEntity
79000 usd
CY2023Q3 us-gaap Net Income Loss
NetIncomeLoss
-5364000 usd
CY2022Q3 us-gaap Net Income Loss
NetIncomeLoss
-2926000 usd
us-gaap Net Income Loss
NetIncomeLoss
-12166000 usd
us-gaap Net Income Loss
NetIncomeLoss
-4869000 usd
CY2023Q3 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
259092833 shares
CY2022Q3 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
259092833 shares
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
259092833 shares
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
259092833 shares
CY2023Q3 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
259092833 shares
CY2022Q3 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
259092833 shares
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
259092833 shares
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
259092833 shares
CY2023Q3 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.02
CY2022Q3 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.01
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.05
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.02
CY2023Q3 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.02
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.05
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.02
us-gaap Concentration Risk Credit Risk
ConcentrationRiskCreditRisk
<p style="margin-top: 0pt; margin-bottom: 0pt; font-size: 10pt;"><span style="font-family: 'times new roman', times; font-style: italic; font-size: 10pt; line-height: inherit;">Significant Concentration of Credit Risk</span></p> <p style="margin-top: 0pt; margin-bottom: 0pt; font-size: 6pt;"><span style="font-family: 'times new roman', times; font-size: 10pt; line-height: inherit;"> </span></p> <p style="margin-top: 0pt; margin-bottom: 0pt; text-indent: 27pt; text-align: justify; font-size: 10pt; font-family: 'Times New Roman'; line-height: 1.2;"><span style="font-family: 'times new roman', times; font-size: 10pt; line-height: inherit;"><span style="line-height: inherit;">Sales to our top <span style="border-left: none; border-right: none; line-height: inherit;">three</span> customers aggregated to approximately </span><span style="line-height: inherit;"><span style="line-height: inherit;">43</span>% and <span style="line-height: inherit;">22</span>% of total sales for the <span style="border-left: none; border-right: none; line-height: inherit;"><span style="border-left: none; border-right: none; line-height: inherit;"><span style="border-right: none; border-left: none; line-height: inherit;"><span>three months ended September 30, 2023</span></span></span></span> and <span>2022</span>,</span><span style="line-height: inherit;"><span style="line-height: inherit;"> <span style="color: #000000; font-family: 'Times New Roman'; font-size: 13.3333px; font-variant-ligatures: normal; font-variant-caps: normal; font-weight: 400; letter-spacing: normal; orphans: 2; text-align: justify; text-indent: 36px; text-transform: none; widows: 2; word-spacing: 0px; -webkit-text-stroke-width: 0px; white-space: normal; text-decoration-thickness: initial; text-decoration-style: initial; text-decoration-color: initial; float: none; line-height: inherit; display: inline !important;">respectively and 29</span><span style="color: #000000; font-family: 'Times New Roman'; font-size: 13.3333px; font-variant-ligatures: normal; font-variant-caps: normal; font-weight: 400; letter-spacing: normal; orphans: 2; text-align: justify; text-indent: 36px; text-transform: none; widows: 2; word-spacing: 0px; -webkit-text-stroke-width: 0px; white-space: normal; text-decoration-thickness: initial; text-decoration-style: initial; text-decoration-color: initial; float: none; line-height: inherit; display: inline !important;">% and 23</span></span><span style="color: #000000; font-family: 'Times New Roman'; font-size: 13.3333px; font-style: normal; font-variant-ligatures: normal; font-variant-caps: normal; font-weight: 400; letter-spacing: normal; orphans: 2; text-align: justify; text-indent: 36px; text-transform: none; widows: 2; word-spacing: 0px; -webkit-text-stroke-width: 0px; white-space: normal; text-decoration-thickness: initial; text-decoration-style: initial; text-decoration-color: initial; float: none; display: inline !important; line-height: inherit;"><span style="line-height: inherit;">% of total sales for the <span>nine months ended September 30, 2023</span> and <span>2022</span>, respectively</span></span><span style="line-height: inherit;">.</span></span><span style="line-height: inherit;"> Sales to <span style="line-height: inherit;"><span style="border-left: none; border-right: none; line-height: inherit;">one</span></span> of those customers were approximately <span style="line-height: inherit;">21</span>% and <span style="line-height: inherit;">9</span>% of total sales for the <span style="border-left: none; border-right: none; line-height: inherit;"><span style="border-right: none; border-left: none; line-height: inherit;"><span style="border-left: none; border-right: none; line-height: inherit;"><span>three months ended September 30, 2023</span></span></span></span> and <span style="border-left: none; border-right: none; line-height: inherit;"><span>2022</span></span>,<span style="line-height: inherit;"> respectively<span style="color: #000000; font-family: 'Times New Roman'; font-size: 13.3333px; font-variant-ligatures: normal; font-variant-caps: normal; font-weight: 400; letter-spacing: normal; orphans: 2; text-align: justify; text-indent: 36px; text-transform: none; widows: 2; word-spacing: 0px; -webkit-text-stroke-width: 0px; white-space: normal; text-decoration-thickness: initial; text-decoration-style: initial; text-decoration-color: initial; float: none; line-height: inherit; display: inline !important;">, and 12</span><span style="color: #000000; font-family: 'Times New Roman'; font-size: 13.3333px; font-variant-ligatures: normal; font-variant-caps: normal; font-weight: 400; letter-spacing: normal; orphans: 2; text-align: justify; text-indent: 36px; text-transform: none; widows: 2; word-spacing: 0px; -webkit-text-stroke-width: 0px; white-space: normal; text-decoration-thickness: initial; text-decoration-style: initial; text-decoration-color: initial; float: none; line-height: inherit; display: inline !important;">% and 9</span><span style="color: #000000; font-family: 'Times New Roman'; font-size: 13.3333px; font-variant-ligatures: normal; font-variant-caps: normal; font-weight: 400; letter-spacing: normal; orphans: 2; text-align: justify; text-indent: 36px; text-transform: none; widows: 2; word-spacing: 0px; -webkit-text-stroke-width: 0px; white-space: normal; text-decoration-thickness: initial; text-decoration-style: initial; text-decoration-color: initial; float: none; line-height: inherit; display: inline !important;">% of total sales for the <span>nine months ended September 30, 2023</span> and <span>2022</span>, respectively. </span></span>Accounts receivable from these <span style="line-height: inherit;"><span style="border-left: none; border-right: none; line-height: inherit;">three</span></span> customers were approximately <span style="line-height: inherit;">18</span>% and <span style="line-height: inherit;">28</span>% <span style="text-indent: 27pt; line-height: inherit;">of total accounts receivable as of </span><span style="text-indent: 27pt; line-height: inherit;"><span>September 30, 2023</span> </span><span style="text-indent: 27pt; line-height: inherit;">and </span><span style="text-indent: 27pt; line-height: inherit;"><span>December 31, 2022</span>, </span><span style="text-indent: 27pt; line-height: inherit;">respectively.</span> </span></span></p> <p style="margin-top: 0pt; margin-bottom: 0pt; text-indent: 27pt; text-align: justify; font-size: 10pt; font-family: 'Times New Roman';"><br/></p> <p style="margin-top: 0pt; margin-bottom: 0pt; text-indent: 27pt; text-align: justify; font-size: 10pt; font-family: 'Times New Roman'; line-height: 1.2;"><span style="font-family: 'times new roman', times; font-size: 10pt; line-height: inherit;"><span style="text-indent: 27pt; line-height: inherit;">A <span style="border-left: none; border-right: none; line-height: inherit;"><span>single</span></span> customer represents </span><span style="text-indent: 27pt; line-height: inherit;">3</span><span style="text-indent: 27pt; line-height: inherit;">% and </span><span style="text-indent: 27pt; line-height: inherit;">2</span><span style="text-indent: 27pt; line-height: inherit;">% of total accounts receivable as of </span><span style="text-indent: 27pt; line-height: inherit;"><span>September 30, 2023</span> </span><span style="text-indent: 27pt; line-height: inherit;">and </span><span style="text-indent: 27pt; line-height: inherit;"><span>December 31, 2022</span></span><span style="text-indent: 27pt; line-height: inherit;">, </span><span style="text-indent: 27pt; line-height: inherit;">respectively. This customer is a related party through a director who sits on both the Company’s board of directors and that of the customer.</span></span></p>
CY2023Q3 us-gaap Depreciation
Depreciation
9000 usd
CY2022Q3 us-gaap Depreciation
Depreciation
14000 usd
us-gaap Depreciation
Depreciation
33000 usd
us-gaap Depreciation
Depreciation
38000 usd
CY2023Q3 us-gaap Indefinite Lived Intangible Assets Excluding Goodwill
IndefiniteLivedIntangibleAssetsExcludingGoodwill
120000 usd
CY2022Q4 us-gaap Indefinite Lived Intangible Assets Excluding Goodwill
IndefiniteLivedIntangibleAssetsExcludingGoodwill
120000 usd
CY2023Q3 us-gaap Intangible Assets Gross Excluding Goodwill
IntangibleAssetsGrossExcludingGoodwill
10882000 usd
CY2022Q4 us-gaap Intangible Assets Gross Excluding Goodwill
IntangibleAssetsGrossExcludingGoodwill
10882000 usd
CY2023Q3 us-gaap Lessee Operating Lease Liability Payments Due Year Three
LesseeOperatingLeaseLiabilityPaymentsDueYearThree
1052000 usd
CY2023Q3 us-gaap Lessee Operating Lease Liability Payments Due Year Four
LesseeOperatingLeaseLiabilityPaymentsDueYearFour
306000 usd
CY2023Q3 tlcc Lessee Operating Lease Liability To Be Paid After Year Four
LesseeOperatingLeaseLiabilityToBePaidAfterYearFour
0 usd
CY2023Q3 us-gaap Finite Lived Intangible Assets Accumulated Amortization
FiniteLivedIntangibleAssetsAccumulatedAmortization
10762000 usd
CY2022Q4 us-gaap Finite Lived Intangible Assets Accumulated Amortization
FiniteLivedIntangibleAssetsAccumulatedAmortization
10762000 usd
CY2023Q3 us-gaap Intangible Assets Net Excluding Goodwill
IntangibleAssetsNetExcludingGoodwill
120000 usd
CY2022Q4 us-gaap Intangible Assets Net Excluding Goodwill
IntangibleAssetsNetExcludingGoodwill
120000 usd
CY2023Q3 us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
0 usd
CY2022Q3 us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
29000 usd
us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
0 usd
us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
87000 usd
CY2023Q3 us-gaap Long Term Debt
LongTermDebt
95349000 usd
CY2022Q4 us-gaap Long Term Debt
LongTermDebt
97381000 usd
CY2023Q3 us-gaap Long Term Debt Current
LongTermDebtCurrent
95349000 usd
CY2022Q4 us-gaap Long Term Debt Current
LongTermDebtCurrent
97381000 usd
CY2023Q3 us-gaap Long Term Debt Noncurrent
LongTermDebtNoncurrent
0 usd
CY2022Q4 us-gaap Long Term Debt Noncurrent
LongTermDebtNoncurrent
0 usd
CY2022Q4 us-gaap Class Of Warrant Or Right Number Of Securities Called By Warrants Or Rights
ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights
4500000 shares
CY2022Q4 us-gaap Class Of Warrant Or Right Exercise Price Of Warrants Or Rights1
ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1
0.01
tlcc Class Of Warrant Or Right Granted During Period Number Of Securities Called By Warrants Or Rights
ClassOfWarrantOrRightGrantedDuringPeriodNumberOfSecuritiesCalledByWarrantsOrRights
0 shares
tlcc Class Of Warrant Or Right Granted During Period Exercise Price Of Warrants Or Rights
ClassOfWarrantOrRightGrantedDuringPeriodExercisePriceOfWarrantsOrRights
0
tlcc Class Of Warrant Or Right Cancelled During Period Number Of Securities Called By Warrants Or Rights
ClassOfWarrantOrRightCancelledDuringPeriodNumberOfSecuritiesCalledByWarrantsOrRights
0 shares
tlcc Class Of Warrant Or Right Canceled During Period Exercise Price Of Warrants Or Rights
ClassOfWarrantOrRightCanceledDuringPeriodExercisePriceOfWarrantsOrRights
0
tlcc Class Of Warrant Or Right Exercised During Period Number Of Securities Called By Warrants Or Rights
ClassOfWarrantOrRightExercisedDuringPeriodNumberOfSecuritiesCalledByWarrantsOrRights
0 shares
tlcc Class Of Warrant Or Right Exercised During Period Exercise Price Of Warrants Or Rights
ClassOfWarrantOrRightExercisedDuringPeriodExercisePriceOfWarrantsOrRights
0
CY2023Q3 us-gaap Class Of Warrant Or Right Number Of Securities Called By Warrants Or Rights
ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights
4500000 shares
CY2023Q3 us-gaap Class Of Warrant Or Right Exercise Price Of Warrants Or Rights1
ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1
0.01
CY2023Q3 us-gaap Lease Cost
LeaseCost
171000 usd
us-gaap Lease Cost
LeaseCost
595000 usd
CY2023Q3 us-gaap Variable Lease Cost
VariableLeaseCost
49000 usd
us-gaap Variable Lease Cost
VariableLeaseCost
148000 usd
CY2023Q3 us-gaap Lessee Operating Lease Liability Payments Remainder Of Fiscal Year
LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear
335000 usd
CY2023Q3 us-gaap Lessee Operating Lease Liability Payments Due Next Twelve Months
LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths
1353000 usd
CY2023Q3 us-gaap Lessee Operating Lease Liability Payments Due Year Two
LesseeOperatingLeaseLiabilityPaymentsDueYearTwo
1333000 usd
CY2023Q3 us-gaap Lessee Operating Lease Liability Payments Due
LesseeOperatingLeaseLiabilityPaymentsDue
4379000 usd
CY2023Q3 us-gaap Lessee Operating Lease Liability Undiscounted Excess Amount
LesseeOperatingLeaseLiabilityUndiscountedExcessAmount
534000 usd
CY2023Q3 us-gaap Operating Lease Liability
OperatingLeaseLiability
3845000 usd
CY2023Q3 us-gaap Sublease Income
SubleaseIncome
163000 usd
us-gaap Sublease Income
SubleaseIncome
488000 usd
CY2023Q3 us-gaap Operating Lease Payments
OperatingLeasePayments
318000 usd
us-gaap Operating Lease Payments
OperatingLeasePayments
1064000 usd
CY2023Q3 us-gaap Operating Lease Weighted Average Remaining Lease Term1
OperatingLeaseWeightedAverageRemainingLeaseTerm1
P3Y6M
CY2023Q3 us-gaap Operating Lease Weighted Average Remaining Lease Term1
OperatingLeaseWeightedAverageRemainingLeaseTerm1
P3Y6M
CY2023Q3 us-gaap Operating Lease Weighted Average Discount Rate Percent
OperatingLeaseWeightedAverageDiscountRatePercent
0.0825 pure
CY2023Q3 us-gaap Operating Lease Weighted Average Discount Rate Percent
OperatingLeaseWeightedAverageDiscountRatePercent
0.0825 pure
CY2023Q3 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
500000000 shares
CY2023Q3 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.001
CY2023Q3 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
0 shares
CY2023Q3 us-gaap Common Stock Shares Subscribed But Unissued
CommonStockSharesSubscribedButUnissued
1528384 shares
CY2023Q3 us-gaap Common Stock Share Subscribed But Unissued Subscriptions Receivable
CommonStockShareSubscribedButUnissuedSubscriptionsReceivable
30000 usd
CY2023Q3 tlcc Subscription Receivable Annual Interest Rate
SubscriptionReceivableAnnualInterestRate
0.05 pure

Files In Submission

Name View Source Status
0001753926-23-001491-index-headers.html Edgar Link pending
0001753926-23-001491-index.html Edgar Link pending
0001753926-23-001491.txt Edgar Link pending
0001753926-23-001491-xbrl.zip Edgar Link pending
ex311_1.htm Edgar Link pending
ex321_2.htm Edgar Link pending
Financial_Report.xlsx Edgar Link pending
MetaLinks.json Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R29.htm Edgar Link pending
R3.htm Edgar Link pending
R30.htm Edgar Link pending
FilingSummary.xml Edgar Link unprocessable
tlcc-20230930_cal.xml Edgar Link unprocessable
tlcc-20230930_def.xml Edgar Link unprocessable
R31.htm Edgar Link pending
R32.htm Edgar Link pending
R33.htm Edgar Link pending
R34.htm Edgar Link pending
R35.htm Edgar Link pending
R36.htm Edgar Link pending
R37.htm Edgar Link pending
R38.htm Edgar Link pending
R39.htm Edgar Link pending
R4.htm Edgar Link pending
R40.htm Edgar Link pending
R41.htm Edgar Link pending
R42.htm Edgar Link pending
R43.htm Edgar Link pending
R44.htm Edgar Link pending
R45.htm Edgar Link pending
R46.htm Edgar Link pending
R47.htm Edgar Link pending
R5.htm Edgar Link pending
R6.htm Edgar Link pending
R7.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending
tlcc-20230930.htm Edgar Link pending
tlcc-20230930.xsd Edgar Link pending
tlcc-20230930_lab.xml Edgar Link unprocessable
tlcc-20230930_pre.xml Edgar Link unprocessable
tlcc-20230930_htm.xml Edgar Link completed